Trademark Overview
On Wednesday, July 31, 2024, a trademark application was filed for REYOBIQ with the United States Patent and Trademark Office. The USPTO has given the REYOBIQ trademark a serial number of 98675300. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 31, 2024. This trademark is owned by Plus Therapeutics, Inc.. The REYOBIQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and radiotherapeutic preparations, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancers